Once the desired HA and NA vRNAs have been combined with the vaccine virus backbone, the resulting egg-propagated vaccine viruses are amplified in embryonated chicken eggs, which remain the most widely used platform for human influenza vaccine production (https://www.cdc.gov/prevent/cell-based.htm; accessed on 31 July 2023). Here, XK is linked to influenza.